As per the latest research report titled ‘Atrial Fibrillation Devices Market Size By Products (EP Ablation Catheters {Radiofrequency, Laser, Cryoablation, Ultrasound, Microwave}, EP Diagnostic Catheters {Fixed Curve Catheters, Steerable Catheters, Advanced Mapping Catheters}, Mapping and Recording Systems, Cardiac Monitors or Implantable Loop Recorder, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices), By End-use (Hospitals, Cardiac Centres, Ambulatory Surgical Centres) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Poland, Switzerland, Belgium, Czech Republic, Netherlands, Sweden, Hungary, Austria, Portugal, Denmark, Norway, Finland, Ireland, Turkey, China, Japan, India, Australia, South Korea, Taiwan, New Zealand, Singapore, Brazil, Argentina, Venezuela, Columbia, Mexico, South Africa, Saudi Arabia, UAE, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025’, available with MarketStudyReport, global atrial fibrillation devices market is anticipated to exceed USD 12.5 billion in valuation by the year 2025.

The high adoption of advanced technologies, availability of sophisticated healthcare infrastructure, favorable reimbursement scenario, rising prevalence of cardiovascular diseases, growing geriatric population, and the rise in rheumatic valvular heart diseases are some of the major factors driving the growth of global atrial fibrillation devices market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/1979116/  

Based on product landscape, the report cites that EP ablation catheters segment expected to record a 14.4% CAGR over the review period, owing to increasing preference for minimally invasive surgeries and surging investments in R&D activities of such devices.

Moving on to end-user terrain, global atrial fibrillation devices industry size from the hospital segment was valued at around USD 2,483.4 million in 2018 and is estimated to witness robust growth over the analysis period, primarily attributed to the rising number of multi-specialty hospitals and increasing volume of hospital admissions for atrial fibrillation in developed countries.

Geographically, the U.S market is expected to witness a y-o-y growth rate of 13.9% during the forecast period, due to the easy availability of cutting-edge technologies and rising healthcare expenditure.

Meanwhile, China market was valued at USD 324.7 million in 2018 and is expected to observe stellar growth in the subsequent years, owing to the rising prevalence of cardiovascular diseases and growing healthcare expenditure.

AtriCure Inc., Biotronik, CardioFocus Inc., Johnson & Johnson (Biosense Webster), Siemens Healthineers AG, Abbott Laboratories (St. Jude Medical), Boston Scientific Corporation, Hansen Medical Inc., Medtronic plc, and Stereotaxis Inc. are some of the major leading companies of global atrial fibrillation devices market.